Advertisement
Screener

RALLYBIO CORPORATION (RLYB) Number of Operating Segments

2.8 / 5 stars · 68/120 Roast Me

RALLYBIO CORPORATION Number of Operating Segments

RALLYBIO CORPORATION (RLYB) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Segment Reporting

us-gaap:NumberOfOperatingSegments · last filed 2026-08-06

  • RALLYBIO CORPORATION number of operating segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
  • RALLYBIO CORPORATION number of operating segments for the quarter ending 2025-03-31 was 1.00 segment.
  • RALLYBIO CORPORATION number of operating segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
  • RALLYBIO CORPORATION number of operating segments for fiscal 2024 was 1.00 segment.
Period endNumber of Operating Segments 3 monthNumber of Operating Segments 6 monthNumber of Operating Segments 9 monthNumber of Operating Segments 12 month
2026-06-301.00 segment
10-Q · filed 2026-08-06
2026-03-311.00 segment
10-Q · filed 2026-05-13
2025-12-311.00 segment
10-K · filed 2026-03-16
2025-09-301.00 segment
10-Q · filed 2025-11-06
2025-06-301.00 segment
10-Q · filed 2025-08-07
2025-03-311.00 segment
10-Q · filed 2025-05-08
2024-12-311.00 segment
10-K · filed 2025-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Anixa Biosciences Inc (ANIX)United States$0.096B
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Lifevantage Corp (LFVN)United States$0.078B15.40